In a 22-month period, strains of Staphylococcus aureus resistant to methicillin and multiple aminoglycosides (designated MARS) were recovered from 108 inpatients with nosocomial infections at a hospital in the midwestern United States. Sixty-six of these patients were staying in a burn unit, and 42 were on other hospital wards. Among the patients with burns, MARS were recovered from the burn wounds of 64'10; 32% of the patients with burns had MARS bacteremia. The patients without burns were age-matched with patients with nosocomial infections caused by antibiotic-susceptible strains of S. aureus. Patients from whom MARS were isolated had a longer mean hospital stay (79.6 days vs. 36.9 days; P <0.01), developed infection later (26.5 days vs. 13.5 days after admission; P <0.01), and had received antibiotic therapy before infection more often (81% vs. 38% of patients; P <0.01) than patients in the comparative population. Types of infection and incidences of death and bacteremia were similar in the two groups. Antibiotic-resistant strains of S. aureus may cause serious infections and significant mortality.
cultured from a central venous catheter removed from a burned patient at St. Paul-Ramsey hospital (St. Paul, Minn.) on the 32nd day of hospitalization. By November 1976, strains of S. aureus resistant to methicillin and aminoglycosides (designated MARS) had been recovered from more than 100 inpatients at this hospital. This paper reports some clinical studies of 108 patients from whom MARS were isolated.
Materials and Methods
The clinical microbiology laboratory at the hospital provided isolates of S. aureus that were resistant to methicillin and one or more aminoglycosides when tested by a standard agar diffusion technique [5] . Characterization of isolates as S. aureus required both a positive tube coagulase test and the elaboration of deoxyribonuclease. Production of penicillinase was assessed by Gots test as modified by Haight and Finland [6] . Antimicrobial susceptibility testing was done by broth and agar dilution techniques as previously described [7] using Mueller-Hinton broth or agar (Baltimore Biological Laboratories, Bal-timore, Md.) at pH 7.4 and standard antibiotic powders or solutions provided by their manufacturers. Studies done with trimethoprim and sulfamethoxazole utilized a smaller inoculum (10 3 organisma/ml) and a different medium (diagnostic sensitivity test agar; Oxoid Ltd., Basingstoke, England). In all tests, organisms were incubated for~24 hr at 30 C. Strains of S. aureus (ATCC strain 25923; American Type Culture Collection, Rockville, Md.) and Escherichia coli (ATCC strain 25922) were included as controls. Agar dilution studies used the replicator described by Steers Patients from whom MARS had been isolated between October 1974 and October 1976 were identified from the records of the clinical microbiology laboratory. A case was defined as a patient from whom MARS were recovered on one or more occasions. Infections developing~48 hr after admission were considered hospital-acquired. The clinical records of these patients were reviewed by one of the authors. Host parameters implicated as important in the development of staphylococcal disease were assessed according to previously established criteria [9, 10] . Autopsy records of patients who died were reviewed, and the cause of death was recorded.
The type of infection present was determined from the site(s) from which MARS were recovered. Infection and colonization were distinguished by means of criteria prepared for studies of nosocomial infection [I IJ. In brief, bacterial isolates from normally sterile tissues (blood, intraabdominal contents, pleural cavity, etc.) were always considered significant. Infection of wound or skin was diagnosed only if purulent drainage was present; otherwise, lesions were considered to be colonized. The diagnosis of pneumonia required (1) a positive sputum culture, (2) a chest X ray compatible with pneumonia, and (3) purulent sputum. In all other cases, positive sputum cultures were interpreted as representing colonization.
Burn wound infection caused by MARS was defined by either (1) purulent drainage from burn wounds from which MARS had been recovered or (2)~105 MARS/g of tissue, as determined by an eschar biopsy [12] . When these criteria were not satisfied, the wound was considered to be colonized.
Because nearly all of the patients with burns became infected or colonized with MARS, a control study in this population was not possible. The 42 patients without burns were further evaluated by a case-control investigation. Controls were inpatients during the study period from whom strains of S. aureus susceptible to all antibiotics tested or resistant only to penicillin G had been isolated two or more days after admission. In chronologie order, patients from this population were age-matched by decade with patients in the MARS group. Identical techniques were used in data collection and evaluation for both groups of patients.
Results
Of the 108 patients from whom MARS were isolated between January 29, 1975 , and October 28, 1976, 66 were admitted to the burn unit and 42 were hospitalized on other services.
Susceptibility of MARS isolates to antimicrobial agents.
Isolates of MARS from 91 of the 108 patients were available. Every strain produced penicillinase. Results of agar dilution susceptibility testing with 21 antimicrobial agents are illustrated in figure I . Nearly all of the isolates were resistant to tobramycin, amikacin, and kanamycin ( figure 1, top) . Approximately 75% of the isolates were susceptible to gentamicin, sisomicin, and netilmicin (figure I, top). All of the isolates were resistant to methicillin (!Vnc,1 2.5 JLg/ml) (figure I, bottom). Nearly all of the strains were resistant to clindamycin, erythromycin, josamycin, and minocycline. Tetracycline and chloramphenicol were effective at clinically achievable levels against more than half of the isolates tested. The vast majority of strains were susceptible to cephalothin, and all were inhibited by low concentrations of rifampin, fusidic acid, vancomycin, trimethoprim, and trimethoprimsulfamethoxazole.
Characteristics of patients with burns. The 66 burned patients from whom MARS were recovered all had second-and third-degree burns over 6%-85% of their body surface area (mean, 42.2%). Fifty-five of the patients were male. Most patients (48 of 61) were in good health prior to their burn injury. Five patients were characterized by their physicians as chronic alcoholics. Three patients had a history of ischemic heart Minimum Inhibiting Concentration, microgm. per ml. disease. Two patients had a serum creatinine level of >1.5 mgjl 00 ml on admission. One patient each had phenylketonuria, congenital cyanotic heart disease, asthma, severe obstructive lung disease, and lupus nephritis.
In most patients (64%), MARS were recovered from the burn wound (table I) . MARS were frequently isolated from central venous catheters (36%). Bacteremia was documented in 21 (32%) of the patients.
Silver sulfadiazine was used topically in 60 of the 66 patients. Six patients received no topical therapy. Although systemic antimicrobial agents were administered to 64 of the 66 patients prior to recovery of MARS, most patients received only brief treatment with penicillin G or erythromycin for the prevention of streptococcal infection.
Only one-third of the patients received other antimicrobial agents prior to isolation of MARS.
Antimicrobial therapy for patients with MARS bacteremia varied considerably. All six bacteremic patients (mean burn of 42.3% of body sur- 
t-test).
No such difference was noted for diabetic patients. For both groups of patients, duration of hospitalization was longer in patients receiving antimicrobial agents. When patients in both groups who received antibiotics were compared, the mean duration of hospitalization was longer in the MARS group (86.4 days vs. 42.5 days) (P < 0.01, t-test). The mean durations of hospitalization of patients who did not receive antibiotics in both groups were also different (51.0 days vs.
days)
The infected surgical wound was the most frequent site from which S. aureus was recovered in both groups, but isolation from this site occurred more often in the MARS patients than in the comparative group (P < 0.01, X 2 test) (table 3). With this exception (which must partially reflect a greater number of surgical patients in the MARS group), sites from which S. aureus was isolated were similar in the two populations.
Antibiotic therapy administered during the period from admission of the patient to first recovery of S. aureus is compared for the two populations in table 4. Eighty-one percent of patients in the MARS group and 38% of the comparative population received one or more antibiotics prior to the first isolation of S. aureus (P < 0.01, X 2 test). The use of two or more antibiotics was also more frequent in patients with infection caused by MARS (50%) than in the comparative group (19%) (P < 0.01, X 2 test). Antibiot- Death occurred in 12 (18%) of the 66 patients from whom MARS had been recovered; all were autopsied. The mortality in patients with MARS bacteremia was 30%. In six of these patients, the cause of death was recorded as infection caused by MARS. Four patients who died had bacterial endocarditis; one had myocardial, renal, and pulmonary abscesses; and one had extensive pneumonia.
Characteristics of patients without burns. The patients without burns from whom MARS were recovered and the comparative group of patients were similar. Twenty-seven patients in the MARS group and 21 in the comparative group were male. Thirty-six patients (88%) in the MARS group and 29 patients (69%) in the comparative group were hospitalized on surgical services at the time their infection developed. In the MARS group, arteriosclerotic cardiovascular disease and peripheral vascular disease occurred more often (14 patients vs. four. patients; P < 0.01, Fisher's exact test) than in the comparative population. A difference in distribution was also noted for patients with diabetes mellitus (eight patients in the MARS group vs. one patient in the comparative population; P < 0.05, Fisher's exact test). The two groups did not differ significantly in the frequency of chronic pulmonary disease, renal failure, malignancy, or alcoholism.
Mean duration of hospitalization and mean number of days from admission of the patient to first isolation of S. aureus were significantly greater in the MARS group (both comparisons, P < 0.01, t-test) (table 2). Some variables that might account for these differences were examined independently by means of a modified t-test. Surgical patients from whom MARS were isolated had a longer mean hospital stay (86.5 days) than did surgical admissions in the comparative group (38.7 days) or nonsurgical patients in the MARS group (38.3 days) (both comparisons, P < 0.01, t-test). For patients with arteriosclerotic cardiovascular disease, the mean duration of hospitalization in the MARS group (85.0 days) was significantly longer than in the comparative population (28.0 days) (P < 0.01, ic usage was not significantly different between the two groups when surgical vs. nonsurgical admission and the presence vs. absence of diabetes or vascular disease were examined as independent variables. The number of days from admission to first isolation of S. aureus was greater in both groups among patients who received antibiotics. In the MARS group, however, the difference (29.8 days vs. 12.1 days) was more pronounced than in the comparative group (19.6 days vs. 9.8 days).
Discussion
Significant resistance to antimicrobial agents in isolates of S. aureus has been unusual in the United States in recent years [3, 4, 13] . A report of Kirby-Bauer susceptibility testing of 102,487 isolates of S. aureus recovered in American hospitals in 1975 has recently been published [4] . Most isolates were resistant to penicillin G, 15% were resistant to tetracycline, and 7% were resistant to erythromycin. However,~95% of the isolates were susceptible to nafcillin or oxacillin, cephalosporins, chloramphenicol, clindamycin, gentamicin, and kanamycin.
There is evidence that antibiotic-resistant strains of S. aureus are being isolated with increasing frequency in American hospitals. Outbreaks of infection due to methicillin-resistant staphylococci (previously reported rarely in the United States) have occurred in at least five American hospitals in the past two years [14] [15] [16] [17] [18] . Gentamicin-resistant isolates of S. aureus have also been noted in both the United States and Great Britain [19] [20] [21] .
The strains of staphylococci described here and similar isolates recently observed in France represent a major change in patterns of antimicrobial resistance in S. aureus [22] . Although methicillin-resistant S. aureus are characteristically resistant to other antibiotics (e.g., erythromycin, tetracycline, and chloramphenicol), susceptibility to the newer aminoglycosides (with the pos-sible exception of amikacin) is usual [23, 24] . The strains studied here and the French strains mentioned above are unique because they combine a resistance pattern characteristic of methicillin-resistant S. aureus with the ability to inactivate many of the aminoglycosides.
The frequency of bacteremia and the nature of the infections observed at autopsy support our impression that MARS may cause serious disease in patients with thermal injury. Studies from the Brooke Army Medical Center (San Antonio, Tex.) have similarly demonstrated that serious infection is common in patients from whom multiply resistant strains of S. aureus have been recovered [25] .
The group of patients without burns from whom MARS were recovered and the comparative population were similar in many ways. Notable differences were in the duration of hospitalization, number of days from admission of the patient to first isolation of S. aureus, and antibiotic therapy prior to infection or colonization. The greater length of hospitalization and similar mortality in patients from whom MARS were isolated suggest that these patients had either primary illnesses or complications that required longer hospitalization but that were not more likely to be associated with a fatal outcome. The apparent prolonged time from admission to recovery of S. aureus in the MARS group was not a function of the differences in underlying diseases in the two populations and was evident whether or not antimicrobial agents were given. Although this difference is not totally explicable from our data, it may be partially due to infrequent colonization of personnel and uncommon environmental contamination with MARS [26] .
The more extensive use of antibiotics in the patients from whom MARS were subsequently isolated suggests that antimicrobial therapy may predispose a patient to the development of infection with these staphylococci. Antibiotic usage was not a function of underlying disease or of service of admission. Although the number of days from admission to first isolation of S. aureus was greater in both groups among patients who received antibiotics, the magnitude of this difference was more pronounced in the MARS population. This finding suggests that antibiotic usage does not completely explain the greater number of days from admission to first isolation of S. aureus in the MARS group. Previous studies suggest that the incidence of both colonization and infection with antibiotic-resistant staphylococci is increased following antimicrobial therapy [27] [28] [29] . It is also known that the prevalence of resistant staphylococci within a hospital may increase following extensive use of an antibiotic [30] .
It is unclear whether penicillinase-resistant penicillins or cephalosporins are effective in the treatment of infection due to methicillin-resistant staphylococci [31] . The survival of all six bacteremic patients with burns who were treated with cephalosporins alone would suggest that these agents are effective against MARS. This finding is in contrast to previous studies that report limited usefulness of cephalosporins in the treatment of infection with methicillin-resistant staphylococci [16, 17, 32] .
It has been suggested that there is an inverse relationship between virulence and antibiotic resistance in S. aureus [33] . As best as can be determined from the information presented here, these multiply resistant strains of S. aureus seem no less virulent than other staphylococci that are more susceptible to antimicrobial agents. The results of these studies indicate that strains of S. aureus resistant to methicillin and aminoglycosides may cause serious infection and create formidable problems in antimicrobial therapy. 
